Today: 7 February 2026
Subscribe
Browse Category

NYSE:CVS News 30 December 2025 - 27 January 2026

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth shares fell 18.4% to $286.96 Tuesday after a U.S. proposal signaled Medicare Advantage payments would rise just 0.09% in 2027. The company warned of its first revenue drop since 1989 despite maintaining its 2026 profit outlook. CVS Health and Humana also posted sharp declines. CMS will accept comments on the proposed rates through Feb. 25.
27 January 2026
······
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

The Dow Jones fell 445 points, or 0.9%, to 48,966 in early trading, dragged down by a 20% plunge in UnitedHealth after weak Medicare payment proposals and a downbeat 2026 forecast. U.S. consumer confidence dropped to its lowest since 2014. The S&P 500 and Nasdaq rose, while Humana and CVS also tumbled. Traders watched for earnings and the Fed meeting starting Tuesday.
27 January 2026
····
CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

CVS Health shares fell about 9% in premarket trading after CMS announced a 0.09% net average payment increase for 2027 Medicare Advantage plans, far below investor expectations. The agency set a Feb. 25 deadline for comments and will finalize rates by April 6. UnitedHealth and Humana also dropped in after-hours trading. Insurers face pressure as Medicare Advantage remains a key profit source.
27 January 2026
····
Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

XLV fell 0.51% to $157.48 Friday, trailing the S&P 500, which ended flat. Health insurer CEOs faced House scrutiny over rising premiums and consolidation, with UnitedHealth pledging ACA rebates in 2026. UnitedHealth reports earnings Jan. 27, Regeneron on Jan. 30. Corcept Therapeutics jumped 45% after positive ovarian cancer trial results.
24 January 2026
········
UnitedHealth stock rises as CEO heads to Congress with Obamacare rebate pledge

UnitedHealth stock rises as CEO heads to Congress with Obamacare rebate pledge

UnitedHealth shares rose 1.8% to $353.85 after the company pledged to rebate 2026 ACA marketplace profits amid scrutiny from lawmakers over affordability. Premiums for ACA plans are set to more than double next year, rising to $1,904, according to KFF. Investors await UnitedHealth’s Jan. 27 earnings report for updates on enrollment and policy risks.
22 January 2026
······
UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth stock drops today — what traders are watching before UNH earnings

New York, Jan 16, 2026, 11:53 EST — Regular session UnitedHealth Group Incorporated (UNH) shares dipped roughly 1.3% on Friday, closing at $334.40. As the Dow pulled back, the largest health insurer by market cap turned into one of its biggest drags. (MarketWatch) The pullback follows President Donald Trump’s healthcare proposal, unveiled just a day earlier, which would swap government insurance subsidies for direct payments to consumers—a move that could upend the way coverage is bought and priced. Insurer stocks jumped on Thursday after the announcement, though the plan lacks specifics and faces a split Congress. (Reuters) Investors are watching
16 January 2026
·········
UnitedHealth (UNH) stock slips as Congress summons CEO; investors eye earnings date

UnitedHealth (UNH) stock slips as Congress summons CEO; investors eye earnings date

New York, Jan 9, 2026, 19:28 EST — After-hours UnitedHealth Group shares fell roughly 0.8% on Friday, lingering around $344 in after-hours trading as U.S. lawmakers intensified scrutiny of major insurers ahead of hearings scheduled for later this month. (stockanalysis.com) The hearings are significant as policy uncertainty is creeping back into managed care valuations. Investors have promptly pushed down the group whenever Washington discusses premiums, subsidies, or regulation. UnitedHealth faces tricky timing. It’s gearing up to update guidance for 2026 just as lawmakers prepare to press the company on costs and coverage issues. Leaders of the House Energy and Commerce
10 January 2026
·······
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

New York, Jan 8, 2026, 20:57 (ET) — Market closed U.S. House lawmakers have called on UnitedHealth Group Incorporated (UNH.N) and four other major insurers to testify on coverage affordability later this month, signaling growing Washington scrutiny. UnitedHealth shares rose 1.5% to close at $346.85 on Thursday. The House Energy and Commerce Committee and the Ways and Means Committee extended invitations to UnitedHealth, CVS Health, Cigna, Elevance and Ascendia for testimony on Jan. 22. Reuters The timing is sensitive. Congress is once again locked in a dispute over subsidies under the Affordable Care Act, known as Obamacare, a debate that
9 January 2026
·······
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

New York, January 8, 2026, 13:30 (ET) — Regular session UnitedHealth Group Incorporated shares rose on Thursday after U.S. House lawmakers invited the CEOs of major health insurers to testify on January 22 about coverage affordability, as Republicans debate whether to extend Affordable Care Act subsidies and President Donald Trump has said he plans to meet insurers. The stock was up 1.3% at $346.11 by early afternoon, after trading between $339.99 and $347.79. CVS Health, Cigna and Elevance Health, also named for the hearing, were higher. Reuters The invitation puts Washington back in the middle of the managed-care trade. Hearings
8 January 2026
·······
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

New York, January 7, 2026, 11:10 EST — Regular session UnitedHealth Group Incorporated shares fell more than 2% on Wednesday, tracking a broader retreat in managed-care insurers. The stock was down $8.53 at $340.44 in late morning trading, while Humana slid 1.4% and Cigna dropped 2.1%. The move comes with investors bracing for UnitedHealth’s full-year results later this month, when the company is due to set out 2026 guidance. A key focus is the medical care ratio — the share of premium revenue that goes to medical claims — after a stretch of elevated utilization across the sector. UnitedHealth Group
7 January 2026
··········
UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

New York, January 5, 2026, 11:37 EST — Regular session UnitedHealth Group Inc shares were up 0.8% at $338.94 in late-morning trading on Monday after Barclays raised its price target on the health insurer. The stock has traded between $333.86 and $340.29 so far, with about 2.4 million shares changing hands. The call hits with UnitedHealth set to release full-year 2025 results and 2026 financial guidance on Jan. 27 before the market opens. The company said it will host an 8:00 a.m. ET teleconference with analysts and investors the same day. UnitedHealth Group That timing matters because investors want a
5 January 2026
········
UnitedHealth stock today: UNH rises after hours as traders look ahead to January guidance

UnitedHealth stock today: UNH rises after hours as traders look ahead to January guidance

NEW YORK, December 30, 2025, 5:05 PM ET — After-hours UnitedHealth Group shares were up about 1% at $332.16 in after-hours trading on Tuesday, following the 4 p.m. close. The stock ranged from $329.18 to $336.03 during the day’s session, with about 4.4 million shares traded. The gain came as U.S. stocks ended slightly lower in holiday-thin trading. The S&P 500 slipped 0.14%, the Dow fell 0.20% and the Nasdaq lost 0.23%. Reuters Investors are repositioning as 2025 winds down, and swings can look sharper when volumes are light. “It’s just a healthy rebalancing of allocations more so than an
30 December 2025
······
1 2 3

Stock Market Today

OCBC share price ends lower ahead of Singapore banks’ earnings week — what investors watch next

OCBC share price ends lower ahead of Singapore banks’ earnings week — what investors watch next

7 February 2026
Singapore, Feb 7, 2026, 15:04 SGT — Market closed. Oversea-Chinese Banking Corporation Limited (OCBC) shares ended Friday down 1.03% at S$21.23. The stock traded between S$21.15 and S$21.35, with about 6.19 million shares changing hands. (Investing.com) With the Singapore market shut for the weekend, the focus shifts to the next catalyst rather than Friday’s tape. Investors want a clean read on whether pressure on bank lending spreads is finally easing as rates stabilise and funding costs cool. That matters now because results from Singapore’s three big lenders land in quick succession this month. Analysts have pointed to an end to
ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop